GAMMA Investing LLC Buys 698 Shares of Koninklijke Philips (NYSE:PHG)

GAMMA Investing LLC grew its stake in shares of Koninklijke Philips (NYSE:PHG) by 10.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,148 shares of the technology company’s stock after buying an additional 698 shares during the period. GAMMA Investing LLC’s holdings in Koninklijke Philips were worth $180,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Principal Securities Inc. bought a new stake in Koninklijke Philips during the 4th quarter worth approximately $27,000. Allspring Global Investments Holdings LLC bought a new position in shares of Koninklijke Philips in the first quarter worth $40,000. Fifth Third Bancorp increased its holdings in shares of Koninklijke Philips by 34.4% in the first quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock worth $60,000 after purchasing an additional 770 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Koninklijke Philips in the first quarter worth $91,000. Finally, 1832 Asset Management L.P. boosted its stake in Koninklijke Philips by 42.6% during the first quarter. 1832 Asset Management L.P. now owns 5,945 shares of the technology company’s stock valued at $119,000 after buying an additional 1,777 shares during the period. 13.67% of the stock is owned by hedge funds and other institutional investors.

Koninklijke Philips Price Performance

NYSE:PHG traded up $0.65 during mid-day trading on Tuesday, reaching $28.68. The stock had a trading volume of 766,203 shares, compared to its average volume of 1,049,779. The stock has a market capitalization of $26.96 billion, a P/E ratio of -29.20, a P/E/G ratio of 0.96 and a beta of 0.72. The firm has a 50 day moving average price of $26.42 and a two-hundred day moving average price of $23.65. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 1.16. Koninklijke Philips has a one year low of $17.75 and a one year high of $29.53.

Koninklijke Philips Cuts Dividend

The firm also recently disclosed an annual dividend, which was paid on Thursday, May 9th. Stockholders of record on Friday, May 10th were issued a $0.9154 dividend. The ex-dividend date was Thursday, May 9th. This represents a dividend yield of 3.5%. Koninklijke Philips’s payout ratio is -94.79%.

Analyst Ratings Changes

Several analysts have weighed in on the company. BNP Paribas raised Koninklijke Philips from an “underperform” rating to a “neutral” rating in a report on Tuesday, May 7th. JPMorgan Chase & Co. upgraded shares of Koninklijke Philips from an “underweight” rating to a “neutral” rating in a research report on Tuesday, April 30th. Sanford C. Bernstein raised shares of Koninklijke Philips from a “market perform” rating to an “outperform” rating in a report on Monday, May 13th. UBS Group upgraded shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a research report on Tuesday, April 30th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold”.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.